Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell–Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3

Cinzia Fionda, Giulia Malgarini, Alessandra Soriani, +8

The Journal of Immunology

Che‐1‐induced inhibition of <scp>mTOR</scp> pathway enables stress‐induced autophagy

Agata Desantis, Tiziana Bruno, Valeria Catena, +21

The EMBO Journal

Cell AutophagySignal TransductionMolecular PathwayChe‐1‐induced InhibitionAutophagy +4

Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients

Massimo Breccia, Vincenzo Federico, Roberto Latagliata, +7

Leukemia Research

Myelodysplastic Syndrome PatientsHematological MalignancyBone Marrow FailureAplastic AnemiaClinical Epidemiology +7

Deferasirox treatment for myelodysplastic syndromes: “real-life” efficacy and safety in a single-institution patient population

Massimo Breccia, Paola Finsinger, Giuseppina Loglisci, +8

Annals of Hematology

Hematological MalignancySingle-institution Patient PopulationHematologyPharmacotherapyMedicine +3

Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience

Massimo Martino, Annalisa Pitino, Mercedes Gori, +38

Frontiers in Oncology

Cytomegalovirus InfectionTransplantationViral PersistenceReal-world ExperienceCmv Disease +13

Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma

Claudio Cartoni, Gregorio Antonio Brunetti, Vincenzo Federico, +9

Supportive Care in Cancer

Neuro-oncologyControlled-release OxycodoneInterventional Pain MedicineHealth SciencesPain Medicine +9

Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin’s lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter study

Nicola Di Renzo, Maurizio Musso, Rosanna Scimè, +17

Bone Marrow Transplantation

LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE

Massimo Breccia, Corrado Girmenia, Roberto Latagliata, +7

Mediterranean Journal of Hematology and Infectious Diseases

Reduced Dose-Intensity Subcutaneous Bortezomib Plus Prednisone (VP) Or Plus Cyclophosfamide (VCP) Or Plus Melphalan (VMP) For Newly Diagnosed Multiple Myeloma Patients Older Than 75 Years Of Age

Alessandra Larocca, Federica Cavallo, Valeria Magarotto, +23

Blood

Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)

Domenico Russo, Nicola Polverelli, Michele Malagola, +56

Bone Marrow Transplantation

Nationwide AnalysisTransplantationMarrow TransplantationCovid-19 PandemicStem Cell Transplantation +7